about
Emergency therapy of maternal and fetal arrhythmias during pregnancy.Fetal cardiac arrhythmia detection and in utero therapyCongenital heart block maternal sera autoantibodies target an extracellular epitope on the α1G T-type calcium channel in human fetal hearts.Perinatal outcome in fetuses with heterotaxy syndrome and atrioventricular block or bradycardiaProposal for a new definition of congenital complete atrioventricular block.Cardiac manifestations of neonatal lupus: a review of autoantibody-associated congenital heart block and its impact in an adult population.Treatment of fetal heart block with maternal steroid therapy: case report and review of the literature.Fetal ECG: a novel predictor of atrioventricular block in anti-Ro positive pregnancies.Prenatal diagnosis of complete atrioventricular block associated with structural heart disease: combined experience of two tertiary care centers and review of the literature.Atrioventricular block detected in fetal life: associated anomalies and potential prognostic markers.Fetal echocardiographic evaluation of atrial morphology and the prediction of laterality in cases of heterotaxy syndromes.Genetics of human heterotaxias.Acute therapy of maternal and fetal arrhythmias during pregnancy.Antinuclear antibodies in routine analysis: the relevance of putative clinical associations.Outcome of isolated congenital complete heart block diagnosed in utero.Congenital heart block: clinical features and therapeutic approaches.Isolated congenital atrioventricular block diagnosed in utero: natural history and outcome.Prenatal diagnosis, management and outcome of fetal dysrhythmia: a tertiary fetal medicine centre experience over an eight-year period.Clinical course and outcome of antenatally detected atrioventricular block: experience of a single tertiary centre and review of the literature.Management of a hydropic infant with congenital heart block.Fetal arrhythmias: a 3-year experience.Congenital heart block: do fetal factors fuel the fire from inflammation to fibrosis?Antibodies to amino acid 200-239 (p200) of Ro52 as serological markers for the risk of developing congenital heart block.
P2860
Q33909247-6644D4CB-E8BE-44B6-B459-F460E4448978Q34369640-6A23D293-BEF5-4E10-97FF-131102F346F9Q34988528-150CD03A-8A09-42F6-BC0D-CAEB2F921C43Q35091170-A9FE55EA-B2AF-4D0F-9E43-48B54C56F049Q35182018-5D640A03-F931-4A78-B8AD-464B897A31A7Q35745465-028263A0-C150-4B8B-AD28-AFA1BBE01F75Q35877304-322C059E-F234-4BE9-A553-EEB88DB42ACCQ36057203-FA92528E-7F2D-4E17-8422-CF3CD27C139CQ36153011-C92A61A5-A60B-4236-859E-5C662AE69F98Q36153022-597A91BD-6820-4E01-9E6E-56B57817881FQ36268084-A219DE06-138C-4C1C-AF46-79D867A52F01Q36298333-E788DC08-8A0D-4371-8D8B-30FB94343866Q36583301-61213112-FC8D-4F03-93F7-7C2E3FF45272Q36777796-C19383A3-AA09-4970-9349-6C1682A62CD8Q36829572-99D8517E-681E-4A8E-8C95-5232421E1BB3Q36915673-1246317E-C575-4D0F-8ECC-5C97E905C646Q37196924-FC944CB1-A5E6-4ACA-8670-4752142D1BECQ37893879-7FFCC5DB-8F11-4606-96A0-ECE213D45D1DQ38285431-8F1266BA-B14C-4232-A657-2A27AEF60AD1Q41825019-160F2BEB-1EDA-48BF-8E3C-C18958E76767Q47874526-23F6DBEC-5470-4B71-88F8-819F6D2F924CQ47874628-6179BA9A-CA86-423B-8922-EEDB31F9049BQ51686879-DF92ED1A-4279-472C-BA08-BAF0A5A38B6A
P2860
description
1988 nî lūn-bûn
@nan
1988 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Fetal complete heart block.
@ast
Fetal complete heart block.
@en
Fetal complete heart block.
@nl
type
label
Fetal complete heart block.
@ast
Fetal complete heart block.
@en
Fetal complete heart block.
@nl
prefLabel
Fetal complete heart block.
@ast
Fetal complete heart block.
@en
Fetal complete heart block.
@nl
P2093
P2860
P356
P1476
Fetal complete heart block.
@en
P2093
P2860
P304
P356
10.1136/HRT.60.6.512
P577
1988-12-01T00:00:00Z